Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Hims & Hers Health Inc (NY: HIMS ) 17.77 +0.06 (+0.34%) Official Closing Price Updated: 4:10 PM EDT, Sep 27, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Press Releases about Hims & Hers Health Inc < Previous 1 2 3 4 5 Next > Hims & Hers to Offer Access to Compounded GLP-1 Injections for as Low as $99/Month to U.S. Military, Veterans, Teachers, Nurses and First Responders September 18, 2024 From Hims & Hers Via Business Wire Invest While You Can: Pullbacks on These 3 Stocks Won’t Last Long September 10, 2024 Three stocks stand out for investors to consider as they recently had big selloffs. There are fundamental reasons to believe that these discounts won't last Via MarketBeat Topics Economy Exposures Economy Interest Rates Top 3 Stocks to Watch: Options Traders Bet on Big Gains August 13, 2024 Three stocks have stood out for call option traders to bet on in the coming months as a view for a recovery rally after an S&P 500 sell-off last week Via MarketBeat Topics Stocks Exposures US Equities Hims & Hers Health Inc. (NYSE: HIMS) Near the Top of Equities by Percentage Gain on 2/27 February 27, 2024 Via Investor Brand Network MarketBeat Week in Review – 8/5 - 8/9 August 10, 2024 Stocks were looking for direction to end the week, but next week may bring more volatility with the latest reading on inflation and the start of retail earnings Via MarketBeat Topics Economy Exposures Economy Interest Rates Hims & Hers Reports Stellar Quarter: Stock Set for a Rally August 06, 2024 Hims & Hers stock is showing the market why its fair value is double-digits above where it trades today, with Wall Street analysts to agree Via MarketBeat Topics Bonds ETFs Exposures Debt Markets Hims & Hers Health, Inc. Reports Second Quarter 2024 Financial Results August 05, 2024 From Hims & Hers Via Business Wire Hims & Hers Stock Falls on DexCom Fears: Analysts Predict Rally August 03, 2024 Hims & Hers stock is looking like a worthy dip to watch in the coming months, especially as its decline had nothing to do with company operations Via MarketBeat Can the New CEO Revive This Struggling Telehealth Stock? July 24, 2024 Virtual healthcare provider Teladoc Health Inc. (NYSE: TDOC) stock is trading down 57.8% year-to-date (YTD). The collapse occurred after reporting Q4 2023 Via MarketBeat Topics Earnings Exposures Financial Pharmaceutical Industry Chief Kåre Schultz Joins Hims & Hers Board July 22, 2024 From Hims & Hers Via Business Wire Is This Telehealth Stock a Buy After the Recent Pullback? July 19, 2024 Hims & Hers Health leverages telehealth's accessibility to disrupt traditional healthcare and deliver personalized wellness solutions. Via MarketBeat Hims & Hers to Announce Second Quarter 2024 Financial Results on August 5, 2024 July 15, 2024 From Hims & Hers Via Business Wire Eli Lilly's Stock Surge Driven by GLP-1 Demand June 20, 2024 Shares of Eli Lilly stock are about to hit a new all-time high, sponsored by the pending approval of new weight loss drugs Via MarketBeat Topics Economy Exposures Interest Rates 3 Sector Stars Lead Growth: Foot Locker, Shake Shack, Hims & Hers June 10, 2024 These three stocks are looking to get a chunk of the total added jobs in the economy, meaning that analyst double-digit upside and growth projections are real Via MarketBeat Topics Economy Exposures Economy MarketBeat Week in Review – 6/3 - 6/7 June 08, 2024 Equity markets shrugged off a much hotter-than-expected jobs report, but there could be more volatility after the next readings on inflation come out next week Via MarketBeat Topics Economy Exposures Interest Rates Hims & Hers Health Soars on Generic GLP-1 Rollout Plans June 03, 2024 Him & Hers Health Inc. (NYSE: HIMS) provides a direct-to-consumer (DTC) health and wellness platform. The company was best known for prescribing treatments Via MarketBeat Call Option Volumes Spiked For These 3 Stocks May 30, 2024 Option traders decided to plow into call contracts for these three stocks, investors can see the specific fundamental reasons behind this decision Via MarketBeat LifeMD Can Surge on Its GLP-1 Offerings May 28, 2024 LifeMD is a leading telehealth provider that investors should take note of; the company is entering the GLP-1 market, and its stock could soar as a result Via MarketBeat Hims & Hers Announces Access to GLP-1 Injections, Passing Cost Savings Onto Customers May 20, 2024 From Hims & Hers Via Business Wire Hims & Hers Welcomes Anja Manuel, Foreign Policy Expert, Domestic Regulations Advisor, and Former Diplomat to its Board of Directors May 16, 2024 From Hims & Hers Via Business Wire 3 Stocks That Suddenly Drew in Options Traders May 13, 2024 Three discounted stocks caught the attention of call option buyers last week, and they have Wall Street analysts to back them through double-digit upside. Via MarketBeat Hims & Hers Health Stock Could Become a Wealth Compounder May 07, 2024 Hims & Hers stock could give investors the best of both stability and double-digit upside through EPS projections and price targets, especially after 1Q24 Via MarketBeat Topics Economy Exposures Economy Hims & Hers Health, Inc. Reports First Quarter 2024 Financial Results May 06, 2024 From Hims & Hers Health, Inc. Via Business Wire Hims & Hers to Announce First Quarter 2024 Financial Results on May 6, 2024 April 15, 2024 From Hims & Hers Health, Inc. Via Business Wire Hims & Hers Appoints Christopher Payne, Seasoned Tech Industry Executive, as Newest Board Member April 04, 2024 From Hims & Hers Health, Inc. Via Business Wire 3 Stocks With Unusual Call Option Activity March 26, 2024 Three stocks reported rising call option buying activity could see even higher prices soon. Analysts see the writing on the wall, and traders stampeded in Via MarketBeat Topics Economy Exposures Interest Rates LifeMD Shares Come Back to Life on GLP-1 Business Growth March 19, 2024 LifeMD stock is surging as the company is riding the GLP-1 trend to double-digit revenue growth and projections for 67% earnings growth in 2024 Via MarketBeat Can WeightWatchers Regain its Mojo after Oprah Steps Down? March 13, 2024 WW International Inc. (NASDAQ: WW) (WeightWatchers) has had a disastrous 2024, with its shares collapsing 66.7% year-to-date (YTD). Via MarketBeat Hims & Hers to Participate in Canaccord Genuity's Virtual eCommerce Sustainable Advantage Forum on March 14, 2024 March 11, 2024 From Hims & Hers Health, Inc. Via Business Wire Hims & Hers Stock Rises On Stimulating Earnings Growth March 05, 2024 Telehealth platform Hims & Hers has turned the corner into GAAP profitability and is expanding its product portfolio to increase its addressable audience Via MarketBeat < Previous 1 2 3 4 5 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.